Efficacy of TCA Effect on Varicella Atrophic Scars | NCT00422539

Studies
Efficacy of TCA Effect on Varicella Atrophic Scars

NCT00422539

Sponsor

Shahid Beheshti University of Medical Sciences

Status

Unknown status

Last Update Posted

Jan 17, 2007Estimated

Enrollment

100

Phase

Phase 2

Conditions

Atrophic Varicella Scar

Interventions

70% trichloroacetic acid

Countries

Iran

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Jan 2007

Overall Recruitment Status or Expanded Access Status

Unknown status

Last Known Status

Recruiting

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Mar 2006

Primary Completion Date

Not provided

Completion Date

Not provided

First Submitted Date

Jan 16, 2007

First Submission Date that Met QC Criteria

Jan 16, 2007

First Posted Date

Jan 17, 2007Estimated

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Jan 16, 2007

Last Update Posted Date

Jan 17, 2007Estimated

Description Module

Brief Summary

This study aims to determine the efficacy of 70% trichloroacetic acid on atrophic scars of varicella

Detailed Description

high concentration trichloroacetic acid peeling has been shown to be effective in treating and flattening the atrophic acne scars. According to the lack of an effective and low cost therapy for removing these relative common and nuisance lesions; We aimed to answer that whether we could achieve the same results from 70% TCA on atrophic varicella scars.

Design Module

Study Type

Interventional

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Not provided

Target Follow-Up Duration

Not provided

Phases

Phase 2

Interventional Study Design

Allocation

Biospecimen

No data available

No data is available for this block.

Enrollment

100

Name	Type	Description	Arm Group Labels	Other Names
70% trichloroacetic acid	Drug

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Objective Clearance(before and after photographies were taken)

Secondary Outcomes

Measure	Description	Time Frame
Subjective Clearance(according to the patients satisfaction)
Adverse effects(assessed by clinician as erythema, pigmentary changes, scaring)

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

Atrophic varicella scar on face

Exclusion Criteria:

Active varicella infection
Active Herpetic infection
Previous history of keloid formation

Accepts Healthy Volunteers

Yes

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

15 Years

Maximum Age

45 Years

Standard Ages

ChildAdult

Study Population

Not provided

Sampling Method

Not provided

Contacts/Locations Module

Central Contacts

Name	Role	Phone	Extension	Email
Behrooz Barikbin, M.D.	Contact	98-21-22744393	5	bbarikbin@yahoo.com

Overall Officials

Name	Affiliation	Role
Parviz Toossi, M.D.	Skin Research Center of Shaheed Beheshti medical University	Study Chair
Behrooz Barikbin, M.D.	Skin Research Center of Shaheed Beheshti Medical Universty	Principal Investigator

Locations

Facility	Status	City	State	ZIP	Country	Contacts
Skin Research Center, Shohada-e Tajrish Hospital, shaheed Beheshti Medical University	Recruiting	Tehran	Tehran Province	198994148	Iran

Intervention Browse Module

MeSH Terms

ID	Term
D014238	Trichloroacetic Acid

Ancestor Terms

ID	Term
D062845	Chloroacetates
D000085	Acetates
D000144	Acids, Acyclic
D002264	Carboxylic Acids

Browse Leaves

Not provided

Browse Branches

Not provided